Rhino-orbital-cerebral mucormycosis in COVID-19 patients - Taming the black evil with pharmacological weapons.

Kaur, Kirandeep; Gurnani, Bharat

Kaur, Kirandeep; Gurnani, Bharat.

Kaur K; Consultant Cataract, Pediatric Ophthalmology and Strabismus Services, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Puducherry, India.
Gurnani B; Consultant Cataract, Cornea and Refractive Services, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Puducherry, India.

Indian J Pharmacol ; 53(5): 417-419, 2021.

Article in English | MEDLINE | ID: covidwho-1547555

Subject(s)

Antifungal Agents/therapeutic use; COVID-19/complications; Central Nervous System Fungal Infections/drug therapy; Eye Infections, Fungal/drug therapy; Mucorales/drug effects; Mucormycosis/drug therapy; Nose Diseases/drug therapy; Orbital Diseases/drug therapy; Antifungal Agents/adverse effects; COVID-19/immunology; COVID-19/virology; Central Nervous System Fungal Infections/immunology; Central Nervous System Fungal Infections/microbiology; Eye Infections, Fungal/immunology; Eye Infections, Fungal/microbiology; Host-Pathogen Interactions; Humans; Mucorales/immunology; Mucorales/pathogenicity; Mucormycosis/immunology; Mucormycosis/microbiology; Nose Diseases/immunology; Nose Diseases/microbiology; Orbital Diseases/immunology; Orbital Diseases/microbiology; Risk Factors; SARS-CoV-2/immunology; SARS-CoV-2/pathogenicity; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Orbital Diseases / Eye Infections, Fungal / Nose Diseases / Central Nervous System Fungal Infections / COVID-19 / Mucorales / Mucormycosis / Antifungal Agents Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Indian J Pharmacol Year: 2021 Document Type: Article Affiliation country: Ijp.ijp_392_21

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google